PsyBio Therapeutics (STU:PSYB) Days Payable: 5,078.26 (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PsyBio Therapeutics Days Payable?

PsyBio Therapeutics STU:PSYB Days Payable is 5,078.26 as of Jun. 2023.

PsyBio Therapeutics's average Accounts Payable for the three months ended in Jun. 2023 was €1.28 Mil. PsyBio Therapeutics's Cost of Goods Sold for the three months ended in Jun. 2023 was €0.02 Mil. Hence, PsyBio Therapeutics's Days Payable for the three months ended in Jun. 2023 was 5,078.26.

The historical rank and industry rank for PsyBio Therapeutics's Days Payable or its related term are showing as below:

STU:PSYB's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 112.84
* Ranked among companies with meaningful Days Payable only.

PsyBio Therapeutics's Days Payable increased from Jun. 2022 (1,556.95) to Jun. 2023 (5,078.26). It may suggest that PsyBio Therapeutics delayed paying its suppliers.

PsyBio Therapeutics Days Payable Historical Data

* Premium members only.

The historical data trend for PsyBio Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PsyBio Therapeutics Days Payable Chart

PsyBio Therapeutics Annual Data
Trend Dec21 Dec22
Days Payable
2,541.96 6,395.27

PsyBio Therapeutics Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,556.95 3,867.60 0.00 9,649.69 5,078.26

STU:PSYB vs VRTX, REGN, SGEN: Days Payable Comparison

For the Biotechnology subindustry, PsyBio Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PsyBio Therapeutics Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PsyBio Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where PsyBio Therapeutics's Days Payable falls into.


PsyBio Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

PsyBio Therapeutics's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

Days Payable (A: Dec. 2022 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2021 ) + Accounts Payable (A: Dec. 2022 )) / count ) / Cost of Goods Sold (A: Dec. 2022 )*Days in Period
=( (0.39 + 1.257) / 2 ) / 0.047*365
=0.8235 / 0.047*365
=6,395.27

PsyBio Therapeutics's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

Days Payable (Q: Jun. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Mar. 2023 ) + Accounts Payable (Q: Jun. 2023 )) / count ) / Cost of Goods Sold (Q: Jun. 2023 )*Days in Period
=( (1.281 + 1.279) / 2 ) / 0.023*365 / 4
=1.28 / 0.023*365 / 4
=5,078.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 5,078.26 mean?
PsyBio Therapeutics (STU:PSYB) has a Days Payable of 5,078.26 as of Jun. 2023. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PsyBio Therapeutics and its competitors.
Is PsyBio Therapeutics' Days Payable too high?
PsyBio Therapeutics' current Days Payable is 5,078.26. The Biotechnology industry median Days Payable is 112.84. PsyBio Therapeutics' value of 5,078.26 is 4400.4% above this industry median.
How does PsyBio Therapeutics' Days Payable compare to VRTX and REGN?
PsyBio Therapeutics' Days Payable of 5,078.26 can be compared against companies in the Biotechnology industry. The industry median Days Payable is 112.84. PsyBio Therapeutics' value of 5,078.26 is 4400.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PsyBio Therapeutics's current Days Payable of 5,078.26 is 4400.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PsyBio Therapeutics and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PsyBio Therapeutics's current Days Payable is 5,078.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PsyBio Therapeutics stock overvalued right now?
PsyBio Therapeutics (STU:PSYB) has a current Days Payable of 5,078.26. The current Days Payable is 5,078.26 and 4400.4% above the Biotechnology industry median of 112.84. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For PsyBio Therapeutics (STU:PSYB), the current Days Payable is 5,078.26 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PsyBio Therapeutics Business Description

Address 1624 Washington Street, Denver, CO, USA, 80203
PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental illness and neurological disorders.